InvestorsHub Logo
Followers 5
Posts 973
Boards Moderated 0
Alias Born 03/03/2011

Re: stock_investor post# 1595

Friday, 11/04/2011 6:15:46 PM

Friday, November 04, 2011 6:15:46 PM

Post# of 424038
Ron yes. they have 5 years exclusivity for NCE. Plus, they have a COM patent on pure EPA that will expire in 2021. Everything else is up in the air. The drubbing in the non-rejection letter was unexpected for me esp the LDL neutrality I thought was a surprise finding and was not obvious. I still think there would be buy out from big pharma albeit at lower price than i originally predicted

To Ron,
yes MNTA has been disappointing thus far. it should recover soon. AMRN no complaints...my average cost was <3.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News